You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma, Ovarian Epithelial

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

PRO for Fighting FT in Ovarian Cancer

Not yet recruiting
  • Ovarian Cancer
  • Questionnaires
  • Naples, Italy
    Nation Cancer Institute of Naples, Division of Medical Oncology
Sep 13, 2023

Medical Imaging in Gynecological Cancer (PRODIGYN)

Not yet recruiting
  • Cervix Cancer
  • +2 more
  • FDG-PET/CT and FDG-PET/MRI
  • (no location specified)
May 2, 2023

Ovarian Epithelial Carcinoma, Fallopian Tube Carcinoma, Peritoneal Carcinoma Trial in Sacramento (AHCC, Chemotherapy, Placebo)

Not yet recruiting
  • Ovarian Epithelial Carcinoma
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Feb 27, 2023

Intraperitoneal Chemotherapy Versus Triweekly Chemotherapy

Recruiting
  • Intraperitoneal Chemotherapy, Bevacizumab, Ovarian Cancer
  • Banqiao, New Taipei, Taiwan
    Department of Obstetrics and Gynecology, Far Eastern Memorial Ho
Jan 1, 2023

Platinum-resistant Ovarian Cancer Trial in Shanghai (Oral Topotecan Combined With Anlotinib)

Not yet recruiting
  • Platinum-resistant Ovarian Cancer
  • Oral Topotecan Combined With Anlotinib
  • Shanghai, China
    Xinhua Hospital Affiliated to Shanghai Jiaotong University Schoo
Feb 12, 2023

Elderly Ovarian Cancer Treated With Trabectedin and PLD

Completed
  • Ovarian Cancer
  • Trabectedin and PLD
  • Córdoba, Spain
    Hospital Universitario Reina Sofía
May 22, 2023

Ovarian Cancer Trial in Xiamen (Organoid culture)

Recruiting
  • Ovarian Cancer
  • Organoid culture
  • Xiamen, Fujian, China
    First Affiliated Hospital of Xiamen University
Apr 3, 2023

Epithelial Ovarian Cancer Trial in Toulouse (Patients treated with platinum based-chemo)

Recruiting
  • Epithelial Ovarian Cancer
  • Patients treated with platinum based-chemotherapy
  • Toulouse, France
    Institut Universitaire du Cancer de Toulouse - Oncopole
Aug 2, 2022

Ovarian Cancer Trial in Roma (Blood samples)

Not yet recruiting
  • Ovarian Cancer
  • Blood samples
  • Roma, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Oct 3, 2023

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Beijing (HS-20089)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • Beijing, Beijing, China
    Lingying Wu
Aug 22, 2023

A Real-World Patient-Reported Outcomes Study in Long-Term Use of

Recruiting
  • Ovarian Cancer
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Sep 13, 2023

    Ovarian Cancer, Platinum-resistant Ovarian Cancer Trial in Minsk (Gemcitabine, ELENAGEN)

    Active, not recruiting
    • Ovarian Cancer
    • Platinum-resistant Ovarian Cancer
    • Minsk, Belarus
      Minsk City Clinical Oncology Center
    Jul 27, 2023

    Ovarian Cancer Trial in Guangzhou (Pamiparib/Tamoxifen)

    Not yet recruiting
    • Ovarian Cancer
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Centre
    Dec 30, 2022

    Transforming Ovarian Cancer Diagnostic Pathways

    Not yet recruiting
    • Ovarian Cancer
      • Birmingham, United Kingdom
      • +2 more
      Nov 10, 2023

      Ovarian Cancer Trial

      Not yet recruiting
      • Ovarian Cancer
        • (no location specified)
        Oct 13, 2022

        Ovarian Cancer Trial in Houston (Nivolumab, Etigilimab)

        Not yet recruiting
        • Ovarian Cancer
        • Houston, Texas
          M D Anderson Cancer Center
        Jan 27, 2023

        Ovarian Cancer in Expanded Access Program in Latin America

        Not yet recruiting
        • Ovarian Cancer
        • Observational study
        • (no location specified)
        May 4, 2023

        Ovarian Cancer Trial (68Ga-FAPi-46)

        Not yet recruiting
        • Ovarian Cancer
        • (no location specified)
        Jun 12, 2023

        Ovarian Cancer, Epithelial Trial in Nanjing (Envafolimab, Lenvatinib, VP-16)

        Not yet recruiting
        • Ovarian Cancer, Epithelial
        • Nanjing, Jiangsu, China
          Zhongda Hospital
        Jun 13, 2022

        Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial (Luveltamab tazevibulin, Pegfilgrastim)

        Not yet recruiting
        • Ovarian Cancer
        • +4 more
        • (no location specified)
        May 12, 2023

        Small Cell Carcinoma, Hypercalcaemic Type, Ovarian Cancer Trial in Toronto (Pembrolizumab)

        Active, not recruiting
        • Small Cell Carcinoma, Hypercalcaemic Type
        • Ovarian Cancer
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Centre
        Jan 8, 2023

        Ovarian Cancer Trial (Aribulin;carboplatin;bevacizumab)

        Not yet recruiting
        • Ovarian Cancer
        • (no location specified)
        Jul 20, 2023

        Recurrent Ovarian Cancer Trial in Shanghai (Fuzuloparib Combination with Bevacizumab)

        Not yet recruiting
        • Recurrent Ovarian Cancer
        • Fuzuloparib Combination with Bevacizumab
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Cente
        Apr 14, 2023

        Epithelial Ovarian Cancer Trial in Leiden ([18F]fluoro-PEG-folate PET/CT scan)

        Recruiting
        • Epithelial Ovarian Cancer
        • [18F]fluoro-PEG-folate PET/CT scan
        • Leiden, Zuid-holland, Netherlands
          Leiden University Medical Center
        Aug 17, 2022

        Ovarian Carcinoma Trial (PEP-DC1, OC-DC, PEP-DC2)

        Not yet recruiting
        • Ovarian Carcinoma
        • PEP-DC1
        • +3 more
        • (no location specified)
        Jan 26, 2023